Visibility Score
41/100
AI Mentions
85
AI Search Volume
1.5K
As of June 25, 2026, Tandem Diabetes Care (tandemdiabetes.com) has an AI visibility score of 41 out of 100, based on 85 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 1.5K AI search volume. Compared to peers in the life sciences sector, Tandem Diabetes Care ranks #5 of 6 in AI mention share of voice.
Tandem Diabetes Care is a US-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Tandem Diabetes Care appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Tandem Diabetes Care has 85 total AI mentions across 1 tracked platforms, generating 1.5K in AI search volume.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Tandem Diabetes Care
When AI assistants answer questions involving Tandem Diabetes Care, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Tandem Diabetes Care ranks #5 out of 6 competitors in AI mention share of voice, capturing 1% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Mindray, Masimo, Embecta.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (Mindray) | 985 | 505.0K |
| masimo.com (Masimo) | 430 | 94.2K |
| embecta.com (Embecta) | 127 | 25.6K |
| tandemdiabetes.com (You) | 85 | 1.5K |
| nihonkohden.com (Nihon Kohden) | 60 | 6.9K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.